Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
The emergence or re-emergence of viruses with epidemic and/or pandemic potential, such as Ebola, Zika, Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus 1 and 2 (SARS and SARS-CoV-2) viruses, or new strains of influenza represents significant human health thr...
Main Authors: | Robert J. Geraghty, Matthew T. Aliota, Laurent F. Bonnac |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/4/667 |
Similar Items
-
Comparison of the Old and New - Novel Mechanisms of Action for Anti-coronavirus Nucleoside Analogues
by: Joy E. Thames, et al.
Published: (2022-05-01) -
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
by: Ruben Soto-Acosta, et al.
Published: (2021-12-01) -
Revaluation of biomass-derived furfuryl alcohol derivatives for the synthesis of carbocyclic nucleoside phosphonate analogues
by: Bemba Sidi Mohamed, et al.
Published: (2017-02-01) -
Synthesis and Antiviral Evaluation of 3′-Fluoro-5′-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents
by: Pierre-Yves Geant, et al.
Published: (2020-08-01) -
nucleoside analogues for the treatment of influenza: history and experience
by: K. V. Kasianenko, et al.
Published: (2019-10-01)